Breaking

Republicans charge ahead on Trump budget, setting up marathon Senate votes
Trump wants Musk to stay with administration, says DOGE found something ‘horrible’ today
Alvopetro Announces March 2025 Sales Volumes
Trump confirms National Security Council firings as Waltz’s Signal chat woes snowball
FREEGOLD ANNOUNCES CLOSING OF $42 MILLION BROKERED PRIVATE PLACEMENT FINANCING
Trump’s Sweeping Tariffs Ignite Global Trade War, Drawing Strong Backlash
Here’s a closer look at Trump’s tariff plan: What to know about the new duties
Dr. Oz becomes next head of Medicare and Medicaid Services following approval from full Senate

Politics
Business
World
Investing
Search for:

Investing

Completion of preclinical data package for RAD 402

December 10, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Alvopetro Announces March 2025 Sales Volumes

FREEGOLD ANNOUNCES CLOSING OF $42 MILLION BROKERED PRIVATE PLACEMENT FINANCING

Trump’s Sweeping Tariffs Ignite Global Trade War, Drawing Strong Backlash

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,585)
- Investing (4,472)
- Politics (7,075)
- Uncategorized (3)
- World (5,782)

Disclaimer: startyourinvesting.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 startyourinvesting.com | All Rights Reserved

Top

Politics
Business
World
Investing

Type above and press Enter to search. Press Esc to cancel.